Tag: Food and Drug Adminstration

FDA Holds First OPDP Enforcement Webinar of 2014

Today the U.S. Food and Drug Administration (FDA) Office of Prescription Drug Promotion (OPDP) held its first enforcement webinar of 2014, addressing enforcement actions taken in Q3 and Q4 of 2013.  These enforcement actions included: Q3 2013:  Brovana, Dalfampridine (Ampyra), Naftin, Zevalin Q4 2013:  Aranesp, Benicar, Cedax, Dantrolene Sodium, Diclegis, […]